You just read:

Pharmascience Inc. launches (Pr)pms-TRANDOLAPRIL, first generic bioequivalent to (Pr)MAVIK® available on the market, for the treatment of mild to moderate essential hypertension

News provided by

Pharmascience Inc.

Jul 04, 2018, 09:00 ET